No Data
No Data
No Data
No Data
No Data
Bausch + Lomb Brief: Announcing "Statistically Significant" Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
08:31 AM EDT, 04/25/2024 (MT Newswires) -- Bausch + Lomb Brief: Announcing "Statistically Significant" Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
MT NewswiresApr 25 20:31
FDA Approves Amneal's Generic Version of OTC Narcan
Seeking AlphaApr 24 23:01
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
Bausch Health (BHC) is in a "stronger position" to proceed with a Bausch + Lomb (BLCO) distribution to its shareholders following a recent appellate court ruling that prevents the Food and Drug Admini
MT NewswiresApr 24 00:04
Bausch Health Is Maintained at Sector Perform by RBC Capital
Bausch Health Is Maintained at Sector Perform by RBC Capital
Dow JonesApr 23 23:55
Bausch Health Price Target Cut to $11.00/Share From $12.00 by RBC Capital
Bausch Health Price Target Cut to $11.00/Share From $12.00 by RBC Capital
Dow JonesApr 23 23:55
Royal Bank of Canada: Maintaining the Bausch Health Companies (BHC.US) rating, adjusted from being equal to the general market to being equal to the general market, and the target price was adjusted from $12.00 to $11.00.
Royal Bank of Canada: Maintaining the Bausch Health Companies (BHC.US) rating, adjusted from being equal to the general market to being equal to the general market, and the target price was adjusted from $12.00 to $11.00.
Zhitong FinanceApr 23 23:50
No Data
No Data